Home・Stock List・AxoGen Inc

AxoGen Inc

Closed

SectorHealthcare

47.83 -3.55

Buy Sell

Overview

Share price change

24h

Current

Min

48.17

Max

49.87

Key metrics
By Trading Economics
Income	18M -1.5M
Sales	8.3M 70M
EPS	-0.03
Profit margin	-2.174
Employees	622
EBITDA	15M -2.2M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+13.8% upside

Dividends
By Acuity
Next Earnings	28 Oct 2026

Market Stats
By TradingEconomics
Market Cap	405M 2.6B
Previous open	51.38
Previous close	47.83

News Sentiment

By Acuity

69%

31%

297 / 340 Healthcare

AxoGen Inc Chart

Past performance is not a reliable indicator of future results.

Related News

12 Aug 2026, 19:32 UTC

AxoGen Inc shares are higher today amid strong trading volume and broader market gains, reflecting optimism from recent inflation data.

10 Aug 2026, 19:41 UTC

AxoGen Inc shares are higher, driven by gains in the Health Care Equipment sub-sector and unusually high market volume. The stock remains above its 20-day moving average.

7 Aug 2026, 20:05 UTC

AxoGen Inc shares are higher today amid strong market volume, reflecting a broader upward trend since Thursday's close.

5 Aug 2026, 19:46 UTC

AxoGen Inc shares are lower amid broader market caution following ADP's report of a significant miss in private sector job growth for July.

4 Aug 2026, 20:06 UTC

AxoGen Inc's shares are higher today, continuing a steady climb since Monday's close amid positive market sentiment and broader trends.

3 Aug 2026, 20:02 UTC

News

AxoGen Inc. shares are advancing as trading volume spikes amid strong interest. The company reported a 23.1% revenue increase to $69.7 million for Q2 2026.

31 Jul 2026, 20:06 UTC

AxoGen Inc shares are higher, recovering from an earlier dip. The stock remains above its 20-day moving average, reflecting solid overall performance.

30 Jul 2026, 19:24 UTC

AxoGen Inc shares are higher, supported by significant broader market gains and unusually high trading volume, despite earlier pulling back from session highs.

29 Jul 2026, 20:41 UTC

AxoGen Inc shares are lower in after-market trading amid a broader downturn in U.S. equities and rising crude oil prices linked to geopolitical tensions.

28 Jul 2026, 20:03 UTC

AxoGen Inc. shares are declining today, pulling back from an earlier high amid broader market weakness linked to declines in Asian indices.

27 Jul 2026, 19:16 UTC

AxoGen Inc shares are higher today, continuing a strong upward trend since Friday's close. Broader market sentiment is influenced by declining oil prices.

22 Jul 2026, 20:01 UTC

AxoGen Inc shares are lower in Wednesday's session amid high trading volume, continuing a decline that began Tuesday. No specific news was identified.

21 Jul 2026, 17:46 UTC

AxoGen Inc shares are higher today, having earlier peaked around 3.01% before pulling back. No specific news was identified to explain the movement.

20 Jul 2026, 19:06 UTC

AxoGen Inc. shares are lower during Monday's session, pulling back from earlier highs amid rising Treasury yields and inflation concerns linked to oil prices.

Peer Comparison

Price change

AxoGen Inc Forecast

Price Target

By TipRanks

13.8% upside

12 Months Forecast

Average 55.17 USD 13.8%

High 58 USD

Low 53 USD

Based on 6 Wall Street analysts offering 12 month price targets forAxoGen Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

6 ratings

Buy

Hold

Sell

Based on 6 analysts giving stock ratings to AxoGen Inc - Dist in the past 3 months.

Sentiment

By Acuity

297 / 340 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About AxoGen Inc

Axogen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. Axogen, Inc. is headquartered in Alachua, Florida.